Exosystems, an artificial intelligence (AI)-based digital healthcare company and a member of Born2Global Centre, has succeeded in attracting Series A funding worth $3.9 million from SBI Investment, Laguna Investment, and Korea Technology Finance Corporation.

With the addition of the new investments, the company has now amassed a total of $4.5 million in funding.

South Korea-based startup Exosystems is known for its digital care solution, consisting of a wearable medical device and connected user app, which enables patients undergoing neurorehabilitation or suffering from musculoskeletal disorders to monitor their health and receive appropriate treatment. 

The technology of Exosystems has been verified through clinical research conducted in cooperation with the Seoul National University Bundang Hospital and other prominent Korean medical institutions. The device and its technologies have also been approved by the Korean Ministry of Food and Drug Safety and the CE-MDD (Medical Devices Directive) in Europe.